Target intelligence / Profile preview

Gamma-Aminobutyric Acid-Mediated Inhibition (GABAergic Inhibition)

Target
GABAergic Inhibition
Molecular classification
Neurotransmission, Inhibitory signaling pathway
01

Overview

Gamma-aminobutyric acid (GABA)-mediated inhibition is the primary mechanism by which neuronal excitability is reduced in the central nervous system. It involves the action of GABA on GABAA and GABAB receptors. GABAA receptors are ionotropic receptors that mediate fast inhibition through chloride ion influx, while GABAB receptors are metabotropic receptors that mediate slower, more prolonged inhibition through potassium channel activation and calcium channel inhibition. This inhibitory process is crucial for maintaining the balance between excitation and inhibition in the brain, preventing hyperexcitability, and regulating various neurological functions.

Other names
GABA inhibitionGABAergic neurotransmissionInhibitory neurotransmission (GABA)GABA-mediated neurotransmission
02

Mechanism of action

Enhancement of GABAergic neurotransmission via increased chloride ion conductance (GABAA receptors) or activation of potassium channels and inhibition of calcium channels (GABAB receptors).

03

Biological functions

Neuronal inhibitionRegulation of neuronal excitabilityBalancing excitation and inhibition in neural networksControl of network excitabilityShaping timing and synchronization within neural circuits
04

Disease associations

EpilepsySeizuresAnxiety disordersSleep disordersMuscle spasticityNeurological disorders associated with impaired inhibition
05

Safety considerations

SedationRespiratory depressionToleranceDependenceWithdrawal symptomsDrug interactionsCognitive impairment
06

Interacting drugs

Benzodiazepines

6 more in the full profile.

Beyond the preview

Go deeper on Gamma-Aminobutyric Acid-Mediated Inhibition (GABAergic Inhibition).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-Aminobutyric Acid-Mediated Inhibition (GABAergic Inhibition).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call